{"entity":{"id":"aichi-cancer-center","kind":"institution","name":"Aichi Cancer Center","aka":["愛知県がんセンター"],"tldr":"Nagoya's prefectural cancer centre with a research institute known for cancer epidemiology, molecular carcinogenesis and gastrointestinal oncology.","summary":"Aichi Cancer Center was founded in 1964 as a prefectural cancer hospital with an integrated research institute and is one of Japan's core cancer centres. Its Research Institute has a long tradition in cancer epidemiology (the HERPACC hospital-based case-control study), molecular carcinogenesis and the biology of gastric and lung cancer, including early ALK and EGFR resistance work, while the hospital is a leading Japanese site for gastric, oesophageal, colorectal, breast and haematological cancer trials and endoscopic resection. It participates in JCOG and WJOG and in the SCRUM-Japan genomic screening network. Patients can access a comprehensive genome profiling service and early-phase trials.","asOf":"2026-09-09","links":[{"label":"Aichi Cancer Center (archived copy)","url":"https://web.archive.org/web/20211206023820/https://www.pref.aichi.jp/cancer-center/"}],"tags":[],"related":[],"cancers":["gastric","esophageal","colorectal","breast-hr-positive","nsclc"],"sections":["prevention","diagnostics"],"technologies":["cgp"],"targets":["alk","egfr"],"drugs":[],"companies":["jcog"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["yasumasa-niwa"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Nagoya","country":"JP","lat":35.182,"lng":136.925,"institutionType":"cancer-center","website":"https://web.archive.org/web/20211206023820/https://www.pref.aichi.jp/cancer-center/","programs":["Cancer epidemiology (HERPACC)","Gastrointestinal oncology","Breast cancer","Molecular carcinogenesis"]},"route":"/institutions/aichi-cancer-center/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"}],"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"}],"target":[{"id":"alk","kind":"target","name":"ALK","route":"/targets/alk/"},{"id":"egfr","kind":"target","name":"EGFR","route":"/targets/egfr/"}],"company":[{"id":"jcog","kind":"company","name":"Japan Clinical Oncology Group (JCOG)","route":"/companies/jcog/"}],"person":[{"id":"yasumasa-niwa","kind":"person","name":"Yasumasa Niwa","route":"/people/yasumasa-niwa/"}]}}